Evaluation of using a fixed-dose combination of glibenclamide and metformin compared to glibenclamide co-administered with metformin in type 2 diabetes outpatients

• In: Hospital Pharmacy - Posters
• At: Basel (Switzerland) (2008)
• Type: Poster
• Poster code: HPS-P-013
• By: YEN, Chih-ho (Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan, Re, Taichung, Taiwan, Republic Of China, China Taiwan)
• Co-author(s): Chen, Hsiu-Mei (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
  Liu, Ying-Mei (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
  Cheng, Huang-Chi (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
  Chen, Been-Yuan (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
  
• Abstract:

  Objectives: The study was conducted to evaluate the efficacy, side effects and economic benefits of using a fixed-dose glibenclamide/metformin tablets compared to glibenclamide co-administered with metformin in type 2 diabetes outpatients.
  
  Methods: This retrospective study analyzed type 2 diabetes outpatients, who treated with a fixed-dose..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login